Desoximetasone topical - Taro Pharmaceuticals

Drug Profile

Desoximetasone topical - Taro Pharmaceuticals

Alternative Names: Desoximetasone 0.25% or 0.5% topical spray - Taro Pharmaceuticals USA; Desoximetasone topical spray - Taro Pharmaceuticals; DSXS; Topicort

Latest Information Update: 17 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Medicis Pharmaceutical Corporation
  • Developer Taro Pharmaceuticals USA
  • Class Anti-inflammatories; Corticosteroids; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis
  • Phase III Atopic dermatitis

Most Recent Events

  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 24 Jun 2018 Biomarkers information updated
  • 02 Jan 2018 Taro Pharmaceuticals completes a phase II trial for Plaque psoriasis (In adolescents) in USA (Topical) (NCT02933502)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top